Wearable multimodal sensing for quantifying the cardiovascular autonomic effects of levodopa in parkinsonism
Levodopa is the most common therapy to reduce motor symptoms of parkinsonism. However, levodopa has potential to exacerbate cardiovascular autonomic (CVA) dysfunction that may co-occur in patients. Heart rate variability (HRV) is the most common method for assessing CVA function, but broader monitor...
Saved in:
| Main Authors: | John A. Berkebile, Omer T. Inan, Paul A. Beach |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Network Physiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnetp.2025.1543838/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship between autonomic dysfunction and sexual dysfunctions in Parkinson’s patients
by: Hatice Varlıbaş, et al.
Published: (2025-03-01) -
Parkinson’s Disease Management via Wearable Sensors: A Systematic Review
by: Huma Mughal, et al.
Published: (2022-01-01) -
Applying Wearable Sensors and Machine Learning to the Diagnostic Challenge of Distinguishing Parkinson’s Disease from Other Forms of Parkinsonism
by: Rana M. Khalil, et al.
Published: (2025-02-01) -
Advances in autonomic dysfunction research in Parkinson’s disease
by: Hongjia Xu, et al.
Published: (2025-03-01) -
When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson’s disease?
by: De Luka Silvio R., et al.
Published: (2014-01-01)